Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:00 PM
Ignite Modification Date:
2025-12-24 @ 2:00 PM
NCT ID:
NCT00524095
Eligibility Criteria:
Inclusion Criteria:
* Smokers or former smokers of at least 10 pack-years
* COPD demonstrated by forced spirometry with FEV1 \> 0,7 L, FEV1 post-BD \<60% and FEV1/FVC \< 70%
* Bronchodilator test performed at inclusion or no more than 6 months before inclusion should have been negative (increase in FEV1 \< 200 ml and 12%, 10 minutes after administration of 2 puffs of salbutamol
* Stable phase defined by clinical criteria of the attending investigator, but at least 6 weeks from the last exacerbation
* Informed consent
Exclusion Criteria:
* Patients receiving oral corticosteroids at any dose or another immunosuppressor
* Formal contraindication for sputum collection or impossibility to obtain a sample of sputum valid for analysis.
* Allergy to steroids or macrolides
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Maximum Age:
85 Years
Study:
NCT00524095
Study Brief:
Protocol Section:
NCT00524095